The Washington Post: The history and mystery of Purell
Use it as a supplement, or a Plan B, not as a miracle goo, say UC-affiliated experts
An article in The Washington Post describes the medical and cultural impact of hand sanitizers, predominately Purell, during the COVID-19 virus outbreak. Looking back to the late 1980s, the article explains how the company Gojo developed a clear, alcohol-based, emollient-enriched, disinfecting substance that was dispensed by a pump bottle and required no water at all.
Experts representing UC’s James L. Winkle College of Pharmacy weigh in on the efficacy and proper use of the soap and water alternative. The article quotes Pharmaceutical Sciences Alumna Kelly Dobos, a former Gojo cosmetic chemist who now sits on the college’s Board of Advisors, and Professor K.P. Ananth, director of the cosmetic sciences program at the college.
Note: Some platforms require you to disable the ad blocker.
Featured image/Pablo Delcan for The Washington Post
Related Stories
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Engineers develop deft solution to orient robots in space
March 11, 2026
To keep a repair robot stable while fixing satellites in space, University of Cincinnati engineers took a page from experts in balance: bull riders. UC College of Engineering and Applied Science graduate student James Talavage and Professor Ou Ma looked at simple but effective ways for a robot to maintain orientation while working on a broken satellite in zero gravity.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.